Worst bleeding scores of patients in this study
| Bleeding score . | RTX + rhTPO . | RTX . | Total . | |||
|---|---|---|---|---|---|---|
| Response (n = 61) . | Nonresponse (n = 16) . | Response (n = 27) . | Nonresponse (n = 11) . | Response (n = 88) . | Nonresponse (n = 27) . | |
| 0 | 13.1 (8) | 12.5 (2) | 14.8 (4) | 18.2 (2) | 13.6 (12) | 14.8 (4) |
| 1 | 59.0 (36) | 43.8 (7) | 51.9 (14) | 45.4 (5) | 56.8 (50) | 44.5 (12) |
| 2 | 18.0 (11) | 37.5 (6) | 25.9 (7) | 27.3 (3) | 20.5 (18) | 33.3 (9) |
| 3 | 6.6 (4) | 6.2 (1) | 7.4 (2) | 9.1 (1) | 6.8 (6) | 7.4 (2) |
| 4 | 3.3 (2*) | 0 | 0 | 0 | 2.3 (2*) | 0 |
| Bleeding score . | RTX + rhTPO . | RTX . | Total . | |||
|---|---|---|---|---|---|---|
| Response (n = 61) . | Nonresponse (n = 16) . | Response (n = 27) . | Nonresponse (n = 11) . | Response (n = 88) . | Nonresponse (n = 27) . | |
| 0 | 13.1 (8) | 12.5 (2) | 14.8 (4) | 18.2 (2) | 13.6 (12) | 14.8 (4) |
| 1 | 59.0 (36) | 43.8 (7) | 51.9 (14) | 45.4 (5) | 56.8 (50) | 44.5 (12) |
| 2 | 18.0 (11) | 37.5 (6) | 25.9 (7) | 27.3 (3) | 20.5 (18) | 33.3 (9) |
| 3 | 6.6 (4) | 6.2 (1) | 7.4 (2) | 9.1 (1) | 6.8 (6) | 7.4 (2) |
| 4 | 3.3 (2*) | 0 | 0 | 0 | 2.3 (2*) | 0 |
Data are presented as % (n) of patients.
Two patients had a grade 4 bleeding score: one patient was a prior bleed, and the other (who relapsed in the third month) died of intracranial hemorrhage.